TY  - GEN
AU  - Masuta,Pardeep
AU  - Johri,Geetanjali
AU  - Paul,Manju
TI  - SGLT2 Inhibitors and Euglycemic Ketoacidosis
SN  - 1536-3686
PY  - 2019///0319
KW  - Blood Glucose
KW  - analysis
KW  - Canagliflozin
KW  - adverse effects
KW  - Diabetes Mellitus, Type 2
KW  - blood
KW  - Diabetic Ketoacidosis
KW  - Female
KW  - Glucose
KW  - administration & dosage
KW  - Humans
KW  - Insulin
KW  - therapeutic use
KW  - Middle Aged
KW  - Sodium-Glucose Transporter 2 Inhibitors
N1  - Publication Type: Case Reports; Letter
UR  - https://doi.org/10.1097/MJT.0000000000000587
ER  -